Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review

Emerging strategies in the treatment of advanced hepatocellular carcinoma: the role of targeted therapies

(2011) R. Lord et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Possibility of Adoptive Immunotherapy With Peripheral Blood-derived CD3−CD56+ and CD3+CD56+ Cells for Inducing Antihepatocellular Carcinoma and Antihepatitis C Virus Activity

(2011) Marlen Doskali et al.   JOURNAL OF IMMUNOTHERAPY

Relationship Between Serum Heparanase and Microscopic Venous Invasion in Patients With Hepatocellular Carcinoma

(2010) Gui-Bo Wang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation

(2010) Haiqing Ma et al.   CANCER BIOLOGY & THERAPY

Endoscopic Ultrasound and Fine-needle Aspiration for the Diagnosis of Hepatocellular Carcinoma

(2010) Anurag Maheshwari et al.   Clinics in Liver Disease

Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response

(2010) Alessandro Zerbini et al.   GASTROENTEROLOGY

Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis

(2010) Jian-Hong Zhong et al.   HEPATOLOGY RESEARCH

Dendritic cells fused with allogeneic hepatocellular carcinoma cell line compared with fused autologous tumor cells as hepatocellular carcinoma vaccines

(2010) Jing-Yue Yang et al.   HEPATOLOGY RESEARCH

Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer

(2010) Kenji Ikeda et al.   HEPATOLOGY RESEARCH

Design and rationale for the non-interventional Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib (GIDEON) study

(2010) R. Lencioni et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Radiofrequency ablation for the treatment of HCC – Maybe much more than simple tumor destruction?

(2010) Tim F. Greten et al.   JOURNAL OF HEPATOLOGY

Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment

(2010) Antonio Colecchia et al.   JOURNAL OF HEPATOLOGY

Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma

(2010) Masaki Kaibori et al.   JOURNAL OF SURGICAL ONCOLOGY

Is There a Role for Adjuvant Treatment after Hepatic Resection for Hepatocellular Carcinoma?

(2010) Ann Tan et al.   ONCOLOGY

Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection

(2009) Ming Shi et al.   CLINICAL IMMUNOLOGY

Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial

(2009) Paola Olioso et al.   HEMATOLOGICAL ONCOLOGY

Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas

(2009) De-Sheng Weng et al.   JOURNAL OF IMMUNOTHERAPY

The immunosuppressive tumor microenvironment in hepatocellular carcinoma

(2008) Yan-Li Pang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients

(2008) Lun Cai et al.   CLINICAL IMMUNOLOGY

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

(2008) Dong Hui et al.   DIGESTIVE AND LIVER DISEASE

T Cells Redirected Against Hepatitis B Virus Surface Proteins Eliminate Infected Hepatocytes

(2008) Felix Bohne et al.   GASTROENTEROLOGY

Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004

(2008) Cristina Bosetti et al.   HEPATOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE